Mifepristone vs Misoprostol for Cervical Preparation
This study is comparing two medications, mifepristone and misoprostol, for cervical preparation (softening and opening the cervix) before a procedural abortion. Researchers want to see if one medication is better at achieving the intended dilation (how much the cervix opens) at the time of surgery. You may be able to join if you are a woman between 18 and 45 years old, speak English or Spanish, and are seeking an abortion for a single pregnancy between 12 and 16 weeks. The study is currently unclear on its recruitment status and plans to enroll 94 participants.
- Study design
- This is an interventional study comparing mifepristone and misoprostol, with a planned enrollment of 94 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary outcome is measured at the time of surgery.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Mifepristone vs Misoprostol
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Antoinette Danvers, MD, MSCR, MBA · PRINCIPAL_INVESTIGATOR · Montefiore Medical Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Percentage of participants achieving Intended dilationAt time of surgery
The proportion of participants achieving intended dilation at the start of the procedure will be summarized by treatment group and reported in percentages. Achievement of intended dilation will be determined by the attending surgeon. Overdilation resulting in passage of products of conception prior to time of surgery will be characterized as a treatment failure.